Healthcare Analytics Market

The report "Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Workforce, Population Health), End User (Payer, Hospital, ACO, ASC), AI, Market Insights, Trends - Forecast to 2031" is projected to reach USD 213.27 billion by 2031 from USD 69.74 billion in 2026, at a CAGR of 25.1% from 2026-2031.

Browse 516 market data Tables and 55 Figures spread through 411 Pages and in-depth TOC on "Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Workforce, Population Health), End User (Payer, Hospital, ACO, ASC), AI, Market Insights, Trends - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/healthcare-data-analytics-market-905.html

The key drivers that contribute to the growth of the healthcare analytics market include increased pressures to cut healthcare costs and enhance patient outcomes, increased venture capital investments in healthcare analytics start-up companies, increasing focus on real-world evidence, increasing telemedicine usage, remote monitoring, and increased pressures to cut healthcare costs and enhance patient outcomes. The potential of healthcare analytics to enhance efficiency and overall quality of care has attracted venture capital investment in this area. There are venture capitalists that are funding healthcare analytics start-up companies to enable these companies to create new healthcare analytics that include predictive and prescriptive analytics. The rapid expansion of telemedicine and remote patient monitoring is also contributing significantly to the adoption of healthcare analytics. According to the US Department of Health & Human Services (HHS), around 25 percent of Medicare beneficiaries used telehealth services in ’24, while remote patient monitoring adoption continues to expand across chronic disease management programs. The increasing generation of real-time patient data through connected medical devices, wearable technologies, and virtual care platforms is creating strong demand for advanced analytics tools capable of processing and interpreting large-scale healthcare datasets

The [SR3.1]predictive analytics segment is growing at the fastest rate during the forecast period.

By type, the predictive analytics segment is projected to register the highest growth rate during the forecast period due to the increasing adoption of artificial intelligence (AI), machine learning (ML), and advanced statistical modeling across the healthcare ecosystem. Healthcare organizations are increasingly leveraging predictive analytics to support early disease detection, patient risk stratification, hospital resource planning, fraud detection, and personalized treatment planning. The growing shift toward value-based care and population health management is further accelerating demand for predictive analytics solutions that can identify high-risk patients, reduce avoidable hospitalizations, and improve clinical and financial outcomes.

The increasing volume of healthcare data generated through EHRs, connected medical devices, telehealth platforms, and remote patient monitoring systems is also contributing to segment growth. Predictive analytics solutions are being widely adopted by providers, payers, and life sciences companies to improve operational efficiency, optimize workforce and resource allocation, support clinical decision-making, and reduce healthcare costs. In addition, growing investment in AI-driven healthcare technologies continues to strengthen market expansion. According to the US Food and Drug Administration (FDA), the number of AI/ML-enabled medical devices authorized by the agency surpassed 1,000 by ’25, highlighting the increasing integration of predictive algorithms into healthcare workflows and clinical applications. (fda.gov) The expanding use of predictive analytics in chronic disease management, precision medicine, claims analytics, and real-world evidence generation is expected to further drive strong segment growth throughout the forecast period.

Providers [SR4.1]held the largest share of the healthcare analytics market in 2025.

Providers, including hospitals and health systems, are increasingly adopting healthcare analytics to improve patient care delivery, enhance clinical decision-making, and strengthen operational efficiency. This adoption is being driven by the rising burden of chronic diseases and the need to manage large, complex volumes of patient data generated across electronic health records (EHRs), imaging systems, and digital care platforms. According to the Office of the National Coordinator for Health Information Technology (ONC), 71 percent of U.S. hospitals used predictive analytics integrated with EHR systems in ’24, up from 66 percent in ’23, highlighting the rapid mainstreaming of analytics within provider organizations. The provider segment, therefore, accounts for a significant share of the healthcare analytics market, as hospitals increasingly rely on real-time data insights to reduce readmissions, optimize resource allocation, and improve population health outcomes. AI- and analytics-enabled tools are now widely used for patient risk prediction, workflow optimization, and operational planning across hospital systems. Studies also indicate that hospitals are rapidly expanding use cases beyond clinical prediction into administrative and financial optimization, reflecting broader digital transformation efforts. For example, predictive AI applications in hospitals grew sharply for billing automation (from 36 percent to 61 percent) and scheduling optimization (from 51 to 67 percent) within a single year (’23–’24), underscoring how analytics is becoming embedded in core hospital operations.

North America will dominate the global healthcare analytics market.

The rising [SR5.1]costs of healthcare delivery in North America—driven by higher service utilization, aging populations, a growing burden of chronic disease, and complex care pathways—continue to significantly increase demand for healthcare analytics solutions. According to the US Centers for Medicare & Medicaid Services (CMS), national healthcare expenditure reached approximately USD 5.3 trillion in ’24, growing 7.2 percent year-on-year and accounting for about 18 percent of US GDP. This persistent cost pressure is pushing healthcare organizations to adopt advanced analytics to identify inefficiencies, optimize care delivery, and improve financial sustainability across hospitals, payers, and integrated delivery networks. The market is further strengthened by widespread adoption of electronic health records (EHRs), cloud-based infrastructure, and AI/ML-driven analytics platforms across North America. EHR adoption is now near-universal in US hospitals, with federal interoperability and digital health initiatives continuing to reinforce data availability and integration across care settings. The region also benefits from one of the most mature healthcare data ecosystems globally, supported by large-scale claims databases and real-world data (RWD) assets used for predictive modeling and population health insights. Additionally, investment in healthcare analytics is accelerating, with global digital health funding dominated by AI, analytics, and data platforms—remaining in the multi-billion-dollar range annually and reinforcing strong venture capital interest in predictive and prescriptive healthcare technologies.

The report profiles key players such as Merative (US), Optum, Inc. (US), SAS Institute Inc. (US), Oracle (US), CitiusTech Inc. (US), Inovalon (US), McKesson Corporation (US), MedeAnalytics, Inc. (US), Cotiviti, Inc. (US), and others.

Don’t miss out on business opportunities in healthcare analytics market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com